WASHINGTON, DC (IANS) – Drug makers Dr Reddy’s Laboratories, Sun Pharma and Aurobindo Pharma are recalling their products in the US due to manufacturing issues. According to the latest Enforcement ...

C2 PHARMA, the global leader in ophthalmic APIs announces the launch of its latest API, timolol maleate. The validation campaign for timolol maleate was completed in August 2025, and a Certificate of ...

A South Florida drug maker recalled 199,584 bottles of three ophthalmic solutions because of a “lack of assurance on sterility.” That’s from FDA alert that the recalls from Apotex’s Weston facility ...

FDC Ltd is recalling over 60,000 bottles of Timolol Maleate Ophthalmic Solution in the US due to a manufacturing issue. The recall was initiated due to defective containers. New Delhi, May 9 (PTI) ...

Caplin Steriles Limited, a subsidiary of Caplin Point Laboratories Limited, has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug ...

The company initiated the Class II recall on January 22 this year. (Image Credits: Pixabay) Pharmaceutical companies Glenmark Pharmaceuticals and FDC Ltd are recalling products in the US market due to ...

Drug firms Glenmark Pharmaceuticals and FDC Ltd are recalling products in the US market due to manufacturing issues, ...

Dr Reddy's Laboratories and FDC Ltd are recalling generic medications in the US market due to manufacturing issues, according to the US health regulator. As per the latest Enforcement Report by Food ...

Santen Pharmaceutical Co., Ltd. engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and ...

Please provide your email address to receive an email when new articles are posted on . Timolol maleate 0.5% microdrops delivered with a volume-reducing adaptor provided noninferior IOP reduction ...